封面
市場調查報告書
商品編碼
925300

冠狀動脈繞道手術的全球市場:成長,趨勢,預測(2020年~2025年)

Coronary Artery Bypass Grafting Market - Growth, Trends, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球冠狀動脈繞道手術市場在2020年~2025年間,預測將以約7.8%的年複合成長率成長。帶動市場成長的主要原因,是各種冠狀動脈性心臟病的全球擴大,有利的償付配合措施,及老年人口增加。譬如,根據2018年出版的「Global Health And Wellness Report」 ,美國成人人口近40%診斷出心血管疾病,尋求有效率的治療,冠狀動脈繞道手術和出色的心血管設備的需求高漲,預計成為推動在預測期間內市場成長的要素。

本報告提供全球冠狀動脈繞道手術市場的相關調查,市場機會和趨勢,成長及阻礙因素,各市場區隔和各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 中風和冠狀動脈性心臟病等心臟疾病的全球盛行率上升
    • 技術性進步的產品的利用可能性償付方針
  • 阻礙市場要素
    • 經皮冠狀動脈介入治療等低侵入性治療的採用
    • 非常高價的治療與缺乏先進的醫療保健基礎設施
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 競爭加劇

第5章 市場區隔

  • 各技術
    • 關斷幫浦CABG
    • 開幫浦CABG
    • 其他
  • 各產品及服務
    • 嫁接
    • 牽開器
    • 服務
    • 其他
  • 各終端用戶
    • 醫院
    • 循環系統診所
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • Terumo Medical Corporation
    • Getinge AB
    • Genesee Biomedical Inc
    • Medtronic plc
    • Karl Storz SE & Co KG
    • Scanlan International Inc
    • Neograft Inc
    • Vitalitec International Inc
    • Edwards Lifesciences
    • Stryker Inc

第7章 市場機會及未來趨勢

簡介目錄
Product Code: 67832

The Coronary artery bypass grafting market studied was anticipated to grow with a CAGR of nearly 7.8% during the forecast period. The major factors driving the growth of the market are the global prevalence of various coronary heart diseases, favorable reimbursement initiatives, and rise in the geriatric population. For instance, according to Global Health And Wellness Report published in 2018, nearly 40% of the adult population in United States were diagnosed with a cardiovascular condition in the United States which directly resulted in higher demand for coronary artery bypass procedure and better cardiovascular devices for efficient treatments fueling the growth of the market throughout the forecast period.

Key Market Trends

The On-pump CABG Technology Segment is Expected to Hold the Largest Market Share in the Coronary Artery Bypass Grafting Market

  • The On-pump CABG technology is expected to witness the largest market share in the coronary artery bypass grafting market during the forecast period. This dominance is due to the increased use of various devices such as the oxygenators, stabilizers, and heart-lung machines in CABG procedures fueling the growth of the market. On the other hand, the off-pump CABG segment is anticipated to grow at the fastest CAGR during the forecast period owing to rapid advancements in this technology which enhanced safety, efficiency, minimized chances of bleeding during the surgery and lesser risks of stroke and injuries to the cardiac muscle. Furthermore, increased availability of novel technologies such as the emergence of Totally Endoscopic Robotically Assisted Coronary Artery Bypass (TECAB) in this technology which has gained huge attention in recent years is also expected to fuel the market growth.
  • Based on the end-users, hospitals are expected to account for the largest share in the market due to presence of a huge volume of new cases in the hospitals owing to the high preference of patients suffering from chronic diseases along with the availability of advanced infrastructure which is expected to propel the market growth during the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the overall CABG market throughout the forecast period. The major factors attributing to the growth are a steep rise in the global prevalence of multiple cardiovascular indications like CAD, strokes and atrial fibrillation due to the rise in chronic diseases such as diabetes & obesity necessitating the CABG procedures and thus, rise in demand for surgical grafts and devices. For instance, according to Journal of American Medical Association report - 2018, about 93.3 million adults over the age of 20 in the United States were obese which is the major cause for coronary heart disease which directly drives the growth of market in the region contributing to the outstanding share of revenue propelling the global CABG market.

Competitive Landscape

The Coronary Artery Bypass Grafting market is moderately competitive and consists of several major players. Few of the key players are developing the novel product and technologies to compete with the existing products while others are acquiring and partnering with the other companies trending in the market. For instance, in February 2018, Aesculap, Inc. completed the asset acquisition of Dextera Surgical Inc. Through this acquisition, Aesculap expanded its product portfolio by adding innovative MicroCutter 5/80 staplers, PAS-Port proximal anastomosis system and innovative devices for CABG surgery to its existing medical devices which contributed in the company's growth in the cardiothoracic surgery market which is expected to impel the global CABG market growth throughout the forecast period. Some of the companies which are currently dominating the market are Medtronic Plc, Terumo Medical Corporation, Getinge AB, Genesee Biomedical Inc, and Karl Storz SE & Co KG

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Global Prevalence of Cardiac Disorders such as Strokes and Coronary Heart Diseases
    • 4.2.2 Availability of Technologically Advanced Products and Reimbursement Policies
  • 4.3 Market Restraints
    • 4.3.1 Adoption of Minimally Invasive Procedures like Percutaneous Coronary Interventions.
    • 4.3.2 Highly Expensive Treatments and Lack of Advanced Healthcare Infrastructure.
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Off-pump CABG
    • 5.1.2 On-pump CABG
    • 5.1.3 Others
  • 5.2 By Products and Services
    • 5.2.1 Grafts
    • 5.2.2 Retractors
    • 5.2.3 Services
    • 5.2.4 Others
  • 5.3 By End-Users
    • 5.3.1 Hospitals
    • 5.3.2 Cardiology Clinics
    • 5.3.3 Other
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United states
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Terumo Medical Corporation
    • 6.1.2 Getinge AB
    • 6.1.3 Genesee Biomedical Inc
    • 6.1.4 Medtronic plc
    • 6.1.5 Karl Storz SE & Co KG
    • 6.1.6 Scanlan International Inc
    • 6.1.7 Neograft Inc
    • 6.1.8 Vitalitec International Inc
    • 6.1.9 Edwards Lifesciences
    • 6.1.10 Stryker Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS